Edwards Lifesciences Corporation Impairment of Intangible Assets, Finite-lived
Edwards Lifesciences Corporation (EW) reported Impairment of Intangible Assets, Finite-lived of $40.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-02-25
- Edwards Lifesciences Corporation impairment of intangible assets, finite-lived for the quarter ending 2025-12-31 was $0.00.
- Edwards Lifesciences Corporation impairment of intangible assets, finite-lived for the quarter ending 2025-09-30 was $40.00M.
- Edwards Lifesciences Corporation impairment of intangible assets, finite-lived for the quarter ending 2024-12-31 was $0.00.
- Edwards Lifesciences Corporation impairment of intangible assets, finite-lived for the quarter ending 2024-09-30 was $0.00.
- Edwards Lifesciences Corporation impairment of intangible assets, finite-lived for fiscal 2025 was $40.00M.
- Edwards Lifesciences Corporation impairment of intangible assets, finite-lived for fiscal 2024 was $0.00.
- Edwards Lifesciences Corporation impairment of intangible assets, finite-lived for fiscal 2023 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $40.00M derived: sum of 2 quarters · filed 2026-02-25 | $40.00M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $40.00M 10-Q · filed 2025-11-05 | $40.00M 10-Q · filed 2025-11-05 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |